GlassScriptPhysician profile
George C Wong
NPI 1386672103
$2,720.23
in general payments reported to CMS, 2019-2025
20 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,470 · 2020: $107 · 2021: $208 · 2022: $270 · 2023: $113 · 2024: $377 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $416.90 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $273.99 | 2019-2023 | Tecnis Iol |
| Allergan, INC. | $218.90 | 2019 | |
| Carl Zeiss Meditec, INC. | $178.13 | 2019 | |
| Biotissue Holdings INC. | $127.85 | 2019-2020 | |
| New World Medical,INC. | $127.42 | 2024 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Bausch & Lomb Americas INC. | $125.00 | 2024 | Vyzulta |
| Rayner Intraocular Lenses Limited | $124.99 | 2024 | Rayone Aspheric, Rayone Emv, Rayone Spheric |
| Kala Pharmaceuticals, INC. | $122.07 | 2019 | |
| Sight Sciences, INC. | $122.06 | 2019 | |
| Horizon Therapeutics Plc | $121.84 | 2022 | |
| Harrow Eye, LLC | $114.74 | 2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $113.13 | 2019-2025 | |
| Omeros Corporation | $109.27 | 2021 | |
| Eyevance Pharmaceuticals LLC | $109.10 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $103.52 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $88.16 | 2019 | |
| Ocular Therapeutix, INC. | $60.39 | 2023 | Dextenza |
| Alcon Vision LLC | $50.50 | 2023-2025 | Argos, Rocklatan |
| Boston Scientific Corporation | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.